Title: Long-term real-world outcomes of mepolizumab and benralizumab among biologic-naive patients with severe eosinophilic asthma: experience of 3 years’ therapy.
Citation: J Allergy Clin Immunol Pract
2023;11:2715–2723.
Country: UK | Indication: Asthma
http://tago.ca/37245734